The size of the Synthetic Biology Market in the Asia Pacific was worth USD 1.17 billion in 2019 and is projected to grow at a CAGR of 26.8%, to reach USD 3.83 billion by 2024.
The government and private institutions’ support and the increase in R&D in drug discovery and development is one of the factors that drive the Asia Pacific synthetic biology market. In synthetic biology, Genome Engineering has become the most critical technology. Besides these factors, there are some more factors that can drive the growth of this market such as cheap, multiplex, genomes modification and DNA synthesis technology. Gene editing techniques and large-scale applications are some of the factors that drive the regional market.
The synthetic biology field offers for early scientists as they are open-minded for doing science. The market and training opportunity reflect the immaturity of the area. This field provides many opportunities for biologists to apply in the private sector using their skills. This offered the chance to discuss how to manage risk and earn the acceptance of the public about this disruptive technology.
The factors that restrain the growth of the Asia Pacific synthetic biology market are issue related bio-safety and bio-security, bio-war also but, these are created by some regulatory bodies and the formation of ethical challenges. The matter related to the misuse of synthetic biology or the possibility of accidental release of pathogens into the atmosphere is a challenge to the regional market. Synthetic biology has made changes to the complete approach for the traditional way of combating with new diseases, problems on genetics with advanced computing and design systems.
Besides these challenges, many people see or choose this field as a better and safe career bet for being a scientist. The potential for synthetic biology is to deliver many solutions to global challenges like improving health care, limited environmental damage and creating a wide variety of processes. For improving accuracy and reproductivity, the ability to pool data and models will also be challenging that too without standardization.
This research report has been segmented & sub-segmented into the following categories:
On the basis of region, Asia Pacific is the fastest-growing market segment due to the growing awareness and increasing collaborations with western companies in China and also due to the well-established biotechnology industries in Japan.
Key players in the APAC Synthetic Biology market profiled in this report are Dupont, Intrexon Corporation, Amyris, Inc., Genscript USA, Inc., Integrated Dna Technologies (IDT), Inc., Novozymes, Royal DSM N.V, New England Biolabs, Inc., Synthetic Genomics, Inc. and Thermo Fisher Scientific, Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Tools
5.1.1 Introduction
5.1.2 Chassis Organisms
5.1.3 Cloning and Assembly kits
5.1.4 Oligonucleotide Synthesis
5.1.5 Enzymes
5.1.6 Xeno Nucleic Acid
5.1.7 Y-o-Y Growth Analysis, By Tool
5.1.8 Market Attractiveness Analysis, By Tool
5.1.9 Market Share Analysis, By Tool
5.2 Technology
5.2.1 Introduction
5.2.2 Enabling technologies
5.2.2.1 Gene Synthesis
5.2.2.2 Cloning and Sequencing
5.2.2.3 Genome Engineering
5.2.2.4 Bioinformatics
5.2.2.5 Nanotechnology
5.2.2.6 Site-Directed Mutagenesis
5.2.2.7 Microfluidics
5.2.2.8 Measurement and Modeling
5.2.3 Enabled technologies
5.2.3.1 Next-Generation Sequencing
5.2.3.2 Pathway Engineering
5.2.4 Y-o-Y Growth Analysis, By Technology
5.2.5 Market Attractiveness Analysis, By Technology
5.2.6 Market Share Analysis, By Technology
5.3 Application
5.3.1 Introduction
5.3.2 Medical Applications
5.3.3 Environmental Applications
5.3.4 Industrial Applications
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Tool
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Tool
6.1.4.3 By Technology
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Tool
6.1.5.3 By Technology
6.1.5.4 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Dupont
8.1.1 Overview
8.1.2 Tool Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Intrexon Corporation
8.3 Amyris, Inc.
8.4 Genscript USA, Inc.
8.5 Integrated Dna Technologies
8.6 Novozymes
8.7 Royal DSM N.V
8.8 New England Biolabs
8.9 Synthetic Genomics
8.10 Thermo Fisher Scientific
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
